AbbVie Inc. (ABBV)
Symbol Info
Listed Symbol ABBV
Name AbbVie Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $3.59
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $32,753,000,000
Latest Fiscal EPS $3.68
Price Info
21 Day Moving Average $65.9152
21 Day EMA $65.997940
50 Day Moving Average $70.0358
50 Day EMA $69.156380
200 Day EMA $76.769890
200 Day Moving Average 77.631920
52 Week High $100.23
52 Week Low $62.66
52 Week Change $-30.960700
Alpha 0.002295
Beta 0.9534
Standard Deviation 0.077091
R2 0.184109
Periods 60
Share Information
10 Day Average Volume 9,058,284
20 Day Average Volume 9,907,490
30 Day Average Volume 10,317,482
50 Day Average Volume 11,820,094
Outstanding Shares 1,478,483,838
Float Shares 1,476,811,018
Percent Float 99.89%
Short Interest 45,895,474
Short Percent Float 3.10%
Short Interest Ratio 4.12
Short Date 2019-07-31
Holders
Institutions 2,955
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 65,812,929
Institute Holdings Percent -
Institute Sold Previous 3 Months 170,918,001
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,672,820
Price Change
7 Day Price Change $-1.1500015
7 Day Percent Change -1.75%
21 Day Price Change $-3.3300018
21 Day Percent Change -4.91%
30 Day Price Change $-4.7300034
30 Day Percent Change -6.84%
Month To Date Price Change $-2.19
Month To Date Percent -3.29%
90 Day Price Change $-13.875908
90 Day Percent Change -17.72%
Quarter To Date $-7.197746
Quarter To Date Percent -10.05%
180 Day Price Change $-14.163597
180 Day Percent Change -18.02%
200 Day Price Change $-10.557144
200 Day Percent Change -14.08%
Year To Date $-24.101318
Year To Date Percent -27.22%
Profile
Description AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
Details
Issue Type CS
Market Cap $95,258,713,682
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 1,478,483,838
CEO Richard A. Gonzalez
Employees 30,000
Last Audit UE
Classification
CIK 0001551152
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 1 North Waukegan Road
North Chicago, IL 60064-6400
Website http://www.abbvieinvestor.com
Facisimile
Telephone +1 847 932-7900
Email
Key Ratios
Profitability
EBIT Margin 15.90
EBITDA Margin 21.7
Pre-Tax Profit Margin 23.0
Profit Margin Cont 12.92
Gross Margin 77.40
Profit Margin TOT 12.92
Income Statements
Revenue $32,624,000,000
Revenue Per Share $22.0659
Revenue 3 Years $9.07
Revenue 5 Years $11.05
Valuation Measures
PE Ratio 22.30
Enterprise Value $93,339,912,117
Price To Sales 2.919897
Price To Free Cash 15.800000
PE High Last 5 Years 65.1
Price To Book 39.3
Price To Cash Flow 7.0
PE Low Last 5 Years 16.3
Price To Tangible Book -2.1
Financial Strength
Total Debt To Equity -
Int Coverage 3.6
Current Ratio 0.9
Leverage Ratio -8.6
Quick Ratio 0.6
Long Term Debt To Capital -
Assets
Receivables Turnover 6.3
Invoice Turnover 4.30
Assets Turnover 0.50
Management Effectiveness
Return Assets 6.98
Return On Equity -69.05
Return On Capital -
Dividends
Dividend 3 Years $19.82
Dividend 5 Years $18.08
Ex Dividend Date 2019-07-12 00:00:00.0
Dividend Rate $4.28
Dividend Yield 6.64%
Payment Type Cash


Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.